Aims and Scope:

The International Journal of Tissue Engineering & Regenerative Medicine (IJTERM) is a distinguished and reputable peer-reviewed journal committed to advancing the field of tissue engineering and regenerative medicine. As an esteemed open-access publication, IJTERM offers researchers, clinicians, and scientists an opportunity to disseminate their groundbreaking findings and contribute to the growth of effective regenerative medicine therapies.

IJTERM covers a broad spectrum of topics that are pivotal to the field of tissue engineering and regenerative medicine. Stem cell biology serves as a fundamental pillar, with a focus on the exploration of stem cell sources, differentiation pathways, and their potential applications in tissue repair and regeneration. Research articles shedding light on the therapeutic potential of stem cells, including pluripotent stem cells, mesenchymal stem cells, and induced pluripotent stem cells, contribute to the development of innovative regenerative medicine approaches.

Biomaterials play a critical role in tissue engineering and regenerative medicine, serving as scaffolds or carriers for cells and bioactive molecules. IJTERM welcomes articles that delve into the design, synthesis, characterization, and functionalization of biomaterials, as well as their interactions with host tissues. Investigations exploring novel biomaterials, such as hydrogels, nanoparticles, and 3D-printed constructs, pave the way for the development of advanced regenerative medicine strategies.

Tissue engineering, a core focus of IJTERM, encompasses research on the fabrication and regeneration of functional tissues and organs. This includes investigations into tissue scaffolds, cell-seeding techniques, bioreactors, and biofabrication technologies. By highlighting innovative tissue engineering approaches, the journal fosters advancements in the creation of functional, implantable tissues that can restore or replace damaged organs.

Organ transplantation remains a vital component of regenerative medicine, and IJTERM recognizes its significance in improving patients’ quality of life. The journal encourages research in the field of organ transplantation, including organ preservation, immune modulation, tissue matching, and transplant outcomes. By disseminating knowledge on organ transplantation, IJTERM supports the refinement of transplantation protocols and the exploration of alternative approaches, such as tissue engineering-based organ constructs and xenotransplantation.

In addition to these core areas, IJTERM welcomes articles that explore other aspects related to tissue engineering and regenerative medicine. This includes investigations into bioprinting, gene therapy, tissue vascularization, immunomodulation, and the integration of advanced imaging and sensing technologies in regenerative medicine approaches. By encompassing diverse research areas, the journal fosters interdisciplinary collaboration and facilitates the translation of scientific discoveries into clinical applications.

IJTERM operates with a rigorous peer-review process to ensure the quality and integrity of published articles. Through the expertise of esteemed reviewers and editors, the journal promotes scientific rigor and encourages authors to present well-founded research that contributes to the advancement of tissue engineering and regenerative medicine.

As an open-access journal, IJTERM is committed to facilitating the widespread dissemination of research findings in the field of tissue engineering and regenerative medicine. This accessibility promotes global collaboration, facilitates knowledge sharing, and encourages the development of evidence-based therapies that can revolutionize patient care.

In conclusion, the International Journal of Tissue Engineering & Regenerative Medicine (IJTERM) serves as a leading platform for the publication of cutting-edge research in the field of tissue engineering and regenerative medicine. By providing a forum for knowledge exchange, embracing a comprehensive scope, and upholding the principles of open access and scientific rigor, IJTERM drives advancements in regenerative medicine therapies, offering hope for the development of innovative approaches to tissue repair and organ regeneration.

Classification:

1. Scaffolding
2. Biomaterials
3. Skin Tissue Engineering
4. Tissue Engineered Medical Products (Temps)
5. Tissue Engineering of Bone
6. Tissue Engineering of Muscles
7. Vascular Tissue Engineering
8. Cardiac Tissue Engineering
9. Cartilage Tissue Engineering
10. Organ Engineering
11. Decellularized Matrix Scaffolds
12. Nodular Regeneration
13. Endodontic Regeneration
14. Regenerative Cells
15. Regenerative Therapy
16. Translational Strategies
17. Challenges in Regenerative Medicine
18. Cardiac Regenerative Medicine
19. Mesenchymal Regenerative Medicine
20. Immunological Barriers
21. Tissue Regeneration
22. Cell Therapy
23. Bioartificial Organs
24. Long Fiber Generation